Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studiesBo Wang, Sailimai Man, Cheng Jin et al.|BMC Cancer|2020Cited by 13